Skip to main content
SpringerLink
Log in

Journal Watch

  • Update
  • Published:
Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Reference

Reference

  • Alsop P, Metcalfe S, Evans J. Funding a clinical trial: the perspective of a medicines funder. Pharmacoeconomics 2008; 26 (10): 811–4

    Article  PubMed  Google Scholar 

Reference

Reference

  • Golec J, Vernon J. Measuring US Pharmaceutical industry R&D spending. Pharmacoeconomics 2008; 26 (12): 1005–17

    Article  PubMed  Google Scholar 

Reference

  • Richesson RL, Malloy JF, Paulus K, et al. An automated standardized system for managing adverse events in clinical research networks. Drug Saf 2008; 31 (10): 807–22

    Article  PubMed  Google Scholar 

Reference

  • Aliabadi HM, Shahin M, Brocks DR, et al. Disposition of drugs in block copolymer efmicelle delivery systems: from discovery to recovery. Clin Pharmacokinet 2008; 47 (10): 619–34

    Article  PubMed  CAS  Google Scholar 

Reference

  • Edholm M, Gil Berglund E, Salmonson T. Regulatory aspects of pharmacokinetic profiling in special populations: a European perspective. Clin Pharmacokinet 2008; 47 (11): 693–701

    Article  PubMed  Google Scholar 

Reference

  • Rappange DR, van Baal PHM, van Exel NJA, et al. Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics 2008; 26 (10): 815–30

    Article  PubMed  Google Scholar 

Reference

  • Higgins RA, Gunn SR, Robetorye RS. Clinical application of array-based comparative genomic hybridization for the identification of prognostically important genetic alterations in chronic lymphocytic leukemia. Mol Diag Ther 2008; 12 (5): 271–80

    Article  Google Scholar 

Reference

  • Schunkert H, Konig IR, Erdmann J. Molecular signatures of cardiovascular disease risk: potential for test development and clinical application. Mol Diag Ther 2008; 12 (5): 281–7

    Article  CAS  Google Scholar 

Reference

  • Lonneborg A. Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood. Mol Diag Ther 2008; 12 (5): 307–20

    Article  CAS  Google Scholar 

Reference

  • Lekman M, Paddock S, McMahon FJ. Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Mol Diag Ther 2008; 12 (5): 321–30

    Article  CAS  Google Scholar 

Reference

  • Blanchet B, Jullien V, Vinsonneau C, et al. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients. Clin Pharmacokinet 2008; 47 (10): 635–54

    Article  PubMed  CAS  Google Scholar 

Reference

  • Zhang F, Pasumarthi KBS. Embryonic Stem cell transplantation: promise and progress in the treatment of heart disease. Biodrugs 2008; 22 (6): 361–74

    Article  PubMed  CAS  Google Scholar 

Reference

  • Aires da Silva F, Corte-Real S, Goncalves J. Recombinant antibodies as therapeutic agents: pathways for modeling new biodrugs. Biodrugs 2008; 22 (5): 301–14

    Article  PubMed  CAS  Google Scholar 

Reference

  • Dressman JB, Thelen K, Jantratid E. Towards quantitative prediction of oral drug absorption. Clin Pharmacokinet 2008; 47 (10): 655–67

    Article  PubMed  CAS  Google Scholar 

Reference

  • Niu G, Chen X. Has molecular and cellular imaging enhanced drug discovery and drug development? Drugs R D 2008; 9 (6): 351–68

    Article  PubMed  CAS  Google Scholar 

Reference

  • Hausner E, Fiszman ML, Hanig J, et al. Long-term consequences of drugs on the paediatric cardiovascular system. Drug Saf 2008; 31 (12): 1083–96

    PubMed  Google Scholar 

Reference

  • Balani AR, Grendell JH. Drug-induced pancreatitis: incidence, management and prevention. Drug Saf 2008; 31 (10): 823–37

    Article  PubMed  CAS  Google Scholar 

Reference

  • Ruchlin HS, Insinga RP. A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation. Pharmacoeconomics 2008; 26 (11): 925–35

    Article  PubMed  Google Scholar 

Reference

  • Perry LCA, Jones TD, Baker MP. New approaches to prediction of immune responses to therapeutic proteins during preclinical development. Drugs R D 2008; 9 (6): 385–96

    Article  PubMed  CAS  Google Scholar 

Reference

  • Blair ED. Assessing the value-adding impact of diagnostic-type tests on drug development and marketing. Mol Diag Ther 2008; 12 (5): 331–7

    Article  Google Scholar 

Reference

  • Wijnen PAHM, Drent M, Nelemans PJ, et al. Role of cytochrome P450 Polymorphisms in the development of pulmonary drug toxicity: a case-control study in the Netherlands. Drug Saf 2008; 31 (12): 1125–34

    PubMed  Google Scholar 

Reference

  • Eguale T, Tamblyn R, Winslade N, et al. Detection of adverse drug events and other treatment outcomes using an electronic prescribing system. Drug Saf 2008; 31 (11): 1005–16

    Article  PubMed  Google Scholar 

Reference

  • Hopstadius J, Noren GN, Bate A, et al. Impact of stratification on adverse drug reaction surveillance. Drug Saf 2008; 31 (11): 1035–48

    Article  PubMed  Google Scholar 

Reference

  • Verdel BM, van Puijenbroek EP, Souverein PC, et al. Drug-related nephrotoxic and ototoxic reactions: a link through a predictive mechanistic commonality. Drug Saf 2008; 31 (10): 877–84

    Article  PubMed  Google Scholar 

Reference

  • Edginton AN, Willmann S. Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis. Clin Pharmacokinet 2008; 47 (11): 743–52

    Article  PubMed  Google Scholar 

Reference

  • Ohno Y, Hisaka A, Ueno M, et al. General framework for the prediction of oral drug interactions caused by CYP3A4 induction from in vivo information. Clin Pharmacokinet 2008; 47 (10): 669–80

    Article  PubMed  CAS  Google Scholar 

Reference

  • Lau DT, Briesacher BA, Mercaldo ND, et al. Older patients’ perceptions of medication importance and worth: an exploratory pilot study. Drugs Aging 2008; 25 (12): 1061–75

    Article  PubMed  Google Scholar 

Reference

  • Gooi M, Bell CM. Differences in generic drug prices between the US and Canada. Appl Health Econ Health Pol 2008; 6 (1): 19–26

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Journal Watch. Pharm Med 22, 389–400 (2008). https://doi.org/10.1007/BF03256737

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256737

Search

Navigation